NCT07298694

Brief Summary

This study aims to evaluate whether modifying the EPIC preference list to display combination blood pressure (BP) medications at the top and/or adding "(PREFERRED)" to the beginning of the medication listing increases prescribing of these medications. Combination BP medications are aligned with value-based care guidelines and may improve patient adherence and reduce pill burden. Currently, these medications may be under-prescribed in part due to their low visibility in the EPIC prescribing interface.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,150

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
5mo left

Started Apr 2026

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Apr 2026Oct 2026

First Submitted

Initial submission to the registry

December 11, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 23, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

April 13, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

December 11, 2025

Last Update Submit

April 27, 2026

Conditions

Keywords

HypertensionClinical Decision SupportChoice BehaviorQuality Improvement

Outcome Measures

Primary Outcomes (1)

  • Prescribing of Combination Antihypertensive Medication (y/n)

    Defined as whether a provider prescribes a combination blood pressure medication (e.g., a single pill containing two medication classes) on the day of the patient's appointment. This is measured at the patient level using EHR prescribing data.

    Day of the appointment (1 day)

Other Outcomes (2)

  • Change in Systolic Blood Pressure

    6 months to 1 year after enrollment (whenever a qualifying reading is taken)

  • Change in Diastolic Blood Pressure

    6 months to 1 year after enrollment (whenever a qualifying reading is taken)

Study Arms (2)

Revised Preference List

EXPERIMENTAL

"(PREFERRED)" will be added to the beginning of the preference list for selected BP medications, which will frequently cause these medications to be listed first.

Behavioral: Revising preference list by adding "(PREFERRED)" to combination medication names

No Change to the Preference List

NO INTERVENTION

Clinics will retain the usual EHR preference list order, with no changes to the default medication display.

Interventions

Providers in the intervention group will see "(PREFERRED)" listed before combination blood pressure medication names, which will frequently cause the combination medications to appear at the top of the EHR preference list.

Revised Preference List

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Order placed for a medication starting with any of the following: "amlodipine", "benazepril", "valsartan", "lisinopril", "hctz", "hydrochlorothiazide", "hydro", "losartan"
  • The order is placed at an in-person, virtual (telemed), telephone, or nurse encounter in a clinic included in the study
  • Patient is age 18+
  • \- Order was placed by a clinical leader who was aware of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geisinger

Danville, Pennsylvania, 17822, United States

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 11, 2025

First Posted

December 23, 2025

Study Start

April 13, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations